Review



affinity purified goat polyclonal antibody against human parvalbumin  (Absolute Biotech Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Absolute Biotech Inc affinity purified goat polyclonal antibody against human parvalbumin
    A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical <t>parvalbumin</t> (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.
    Affinity Purified Goat Polyclonal Antibody Against Human Parvalbumin, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/affinity purified goat polyclonal antibody against human parvalbumin/product/Absolute Biotech Inc
    Average 86 stars, based on 1 article reviews
    affinity purified goat polyclonal antibody against human parvalbumin - by Bioz Stars, 2026-06
    86/100 stars

    Images

    1) Product Images from "Deep transcriptome profiling of human hypothalamic agouti-related protein and proopiomelanocortin neurons regulating energy homeostasis"

    Article Title: Deep transcriptome profiling of human hypothalamic agouti-related protein and proopiomelanocortin neurons regulating energy homeostasis

    Journal: bioRxiv

    doi: 10.1101/2025.08.19.671088

    A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical parvalbumin (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.
    Figure Legend Snippet: A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical parvalbumin (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.

    Techniques Used: Preserving, Immunohistochemical staining, Staining



    Similar Products

    affinity purified goat polyclonal antibody against human parvalbumin  (Absolute Biotech Inc)
    86
    Absolute Biotech Inc affinity purified goat polyclonal antibody against human parvalbumin
    A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical <t>parvalbumin</t> (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.
    Affinity Purified Goat Polyclonal Antibody Against Human Parvalbumin, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/affinity purified goat polyclonal antibody against human parvalbumin/product/Absolute Biotech Inc
    Average 86 stars, based on 1 article reviews
    affinity purified goat polyclonal antibody against human parvalbumin - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical parvalbumin (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.

    Journal: bioRxiv

    Article Title: Deep transcriptome profiling of human hypothalamic agouti-related protein and proopiomelanocortin neurons regulating energy homeostasis

    doi: 10.1101/2025.08.19.671088

    Figure Lengend Snippet: A : Schematic overview of histological procedures used to evaluate the combined effects of postmortem delay and immersion fixation (24, 48, or 72 h) on RNA integrity. B : Neocortical tissue samples from a 53-year-old female, processed in the presence of the RNase inhibitor aluminon (ATA; 0.05%), show comparable RNA quality (RIN > 7.0) and yield across different fixation times (Agilent Bioanalyzer; Table S1). C : Experimental design for optimizing RNA preservation using ATA (0.05%) or polyvinyl sulfonic acid (PVSA; 1-10%) during immunohistochemical detection of cortical parvalbumin (PVALB) neurons. D : Both ATA and PVSA provide significant protection against degradation during antigen retrieval at 80 °C, while RNA integrity is severely compromised in the absence of RNase inhibitors; ATA and PVSA (2%) also maintain RNA integrity during IHC performed either at RT or 4 °C (Table S1). E : Effects of ATA (0.05%) and PVSA (2%) on IHC signal quality and background. Both additives enable successful detection of PVALB neurons; however, ATA treatment results in increased nonspecific background staining. Statistical annotations: **p<0.01, ##p<0.00001, ###p<0.000001 by one-way ANOVA followed by Tukey’s HSD.

    Article Snippet: Sections were pretreated with 1% H 2 O 2 and 0.5% Triton X-100 in PBS for 20 minutes, followed by incubation with a commercially available affinity-purified goat polyclonal antibody against human parvalbumin (#EB06776; Everest Biotech; 1:30,000) for either 40 hours at 4 °C or overnight at RT.

    Techniques: Preserving, Immunohistochemical staining, Staining